CAS: 2046-18-6; 4-Phenylbutanenitrile

该化合物其结构特征为有机化合物,其结构特征是附于一个苯基组的丁酰三联链,其分子式为C11H12N,表明碳,氢和氮原子的存在.该化合物的特性,如沸点和熔点等,根据特定条件和纯度而有所不同.在处理该物质时,应注意安全,因为若吸入或摄入,可能会对健康造成危害.总的来说,苯丁基硝基苯是一种多用途化合物,在化学研究和工业应用中具有重大关联性.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号358349-85-6 isopropyl 4-phe... | CAS号10031-93-3 4-苯基丁酸乙酯 | CAS号13214-66-9 4-苯基丁胺 | CAS号1821-12-1 4-苯基丁酸 | CAS号1199-98-0 Benzenebutanamide | CAS号6727-73-7 G-碘丁腈 | CAS号368-47-8 苯基三氟硅烷 | CAS号3360-41-6 4-苯基-1-丁醇 | CAS号591-50-4 碘苯 | CAS号5332-06-9 4-溴丁腈 | CAS号143859-51-2 4-(4-benzoylphe... | CAS号529-34-0 1-四氢萘酮 | CAS号1821-12-1 4-苯基丁酸 | CAS号1199-98-0 Benzenebutanamide | CAS号5343-98-6 3-苯甲酰丙腈 | CAS号65-85-0 苯甲酸 | CAS号13214-66-9 4-苯基丁胺 | CAS号5406-39-3 3-(对甲苯基)丙烷-1-醇 | CAS号30684-06-1 4-苯基丁胺盐酸盐 | CAS号177665-17-7 4-phenylbutanet...

合成工艺路线路线简述

    📜肉桂腈置于rh(Ttp)Me,Sodium Hydride,异丙醇体系中,用 氘代苯,N,N-二甲基甲酰胺 用作溶剂,化学反应 49.0H,反应生成4-苯基丁腈
    参考文献:铑卟啉用iproh催化环丙烷中c-cσ键的区域选择性转移氢解
    标题:铑卟啉用iproh催化环丙烷中c-cσ键的区域选择性转移氢解
    摘要:发现了一种新的铑卟啉以i Proh为氢源催化活化和未活化环丙烷的区域选择性转移氢解反应.通过用金属卟啉铑(II)进行初始自由基取代以生成卟啉烷基铑,然后用i Proh氢解以生成相应的无环烷烃并再生铑,从而确定了环丙烷c-cσ键活化的反应机理.(二)金属卟啉自由基.
    Doi:10.1021/acs.Organomet.9B00290

    海关参考信息

    专利信息


    专利号:US-7094920-B2
    优先权日:2001-05-21
    标 题 :Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters
    发明人:TIKARE RAVEENDRA KHANDURAO
    权利人:FERMENTA BIOTECH LTD
    摘要:A process is described for the stereospecific preparation of an ester of formula (I): wherein * signifies the (R) stereoisomer; R 1 is selected from C 1-6 alkyl, preferably ethyl; and R 2 is hydrogen, a protecting group or a leaving group which process comprises reaction of a nitrile of formula (II): wherein * signifies the (R) stereoisonomer; and Ph is the phenyl group C 6 H 5 with a solution of an inorganic acid in an alcohol and optional conversion of the compound of formula (I) wherein R 2 is H so prepared to any other desired compound of formula (I) by standard methods in the art. The compounds of formula (I) are chiral esters, useful as intermediates in the synthesis of the family of acetylcholine esterase (ACE) inhibitors known as “prilsâ€?, such as lisinopril, cilazapril, enalapril, benazepril, ramipril, delapril, enalaprilat, imidapril, spirapril, trandolapril and others.n n*n nPh-CH 2 —CH 2 —CH(OR 2 )—COOR 1   (I)n n*n nPh-CH 2 —CH 2 —CH(H)—CN  (II)

    专利号:WO-2012131629-A1
    优先权日:2011-03-31
    标题 :A process for preparation of intermediate of moxifloxacin
    发明人:WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    权利人:PIRAMAL HEALTHCARE LTD; WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    摘要:The present invention provides a process for the preparation of racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I, a key intermediate in the synthesis of moxifloxacin or its pharmaceutically acceptable salts. The process comprises reaction of racemic or chiral tetrahydro-6-(phenylmethyl)-1H- pyrrolo[3,4-b]pyridine-5,7(6H)-dione of formula II with a reducing agent, which is a mixture of two agents, that is mixture of dimethyl sulphate and sodium borohydride or aluminum chloride and sodium borohydride used in a molar ratio ranging from 1:1 to 1: 4, in the presence of a polar solvent at a temperature ranging from 15°C to 45°C 10 to obtain racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I having purity ≥ 96%.

    专利号:US-2010278715-A1
    优先权日:2009-04-29
    标 题:Systems, Devices, and/or Methods Regarding Specific Precursors or Tube Control Agent for the Synthesis of Carbon Nanofiber and Nanotube
    发明人:KHE NGUYEN
    权利人:TH LLC
    摘要:Certain exemplary embodiments can comprise, via a tube control agent (TCA) and a metallic catalyst, producing a carbon nanotube. At least some carbon used to form the carbon nanotube can be obtained from a plant, a cellulose product, and/or a cellulosic product. At least some of the carbon can be converted into powder.

    专利号:US-4710513-A
    优先权日:1979-08-17
    标 题:Substituted pyranone inhibitors of cholesterol synthesis
    发明人:WILLARD ALVIN K; NOVELLO FREDERICK C; HOFFMAN WILLIAM F; CRAGOE JR EDWARD J
    权利人:MERCK & CO INC
    摘要:6-Phenyl-, phenylalkyl- and phenylethenyl-4-hydroxytetrahydropyran-2-ones in the 4(R)-trans stereoisomeric forms are potent inhibitors of cholesterol synthesis by virtue of their ability to inhibit the enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

    专利号:US-4459422-A
    优先权日:1979-08-17
    标 题:Substituted pyranone inhibitors of cholesterol synthesis
    发明人:WILLARD ALVIN K; NOVELLO FREDERICK C; HOFFMAN WILLIAM F; CRAGOE JR EDWARD J
    权利人:MERCK & CO INC
    摘要:6-Phenyl-, phenylalkyl- and phenylethenyl-4-hydroxytetrahydropyran-2-ones in the 4(R)-trans stereoisomeric forms are potent inhibitors of cholesterol synthesis by virtue of their ability to inhibit the enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

    专利号:US-4375475-A
    优先权日:1979-08-17
    标 题 :Substituted pyranone inhibitors of cholesterol synthesis
    发明人:WILLARD ALVIN K; NOVELLO FREDERICK C; HOFFMAN WILLIAM F; CRAGOE JR EDWARD J
    权利人:MERCK & CO INC
    摘要:6-Phenyl-, phenylalkyl- and phenylethenyl-4-hydroxytetrahydropyran-2-ones in the 4(R)-trans stereoisomeric forms are potent inhibitors of cholesterol synthesis by virtue of their ability to inhibit the enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kostikov, R. R.; Khlebnikov, A. F.; Sokolov, V. V., Science of Synthesis, (2010) 47, 866.
    摘要:Lubell, W. D.; St-Cyr, D. J.; Dufour-Gallant, J.; Hopewell, R.; Boutard, N.; Kassem, T.; Dörr, A.; Zelli, R., Science of Synthesis Knowledge Updates, (2013) 1, 232.
    摘要:Zhdankin, V. V., Science of Synthesis Knowledge Updates, (2015) 1, 270.
    摘要:Denmark, S.; Chang, W.-T. T., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 400.
    摘要:Faber, K.; Glueck, S. M.; Hammer, S. C.; Hauer, B.; Nestl, B. M., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 3, 571.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知